The U.S. Department of Justice and Drug Enforcement Administration announced a $50 million settlement with Walmart Inc. to resolve allegations that its pharmacies illegally filled thousands of invalid opioid and controlled substance prescriptions from 2013 to 2020. The complaint alleged Walmart’s compliance team knowingly allowed prescriptions from “pill mills” to be filled despite pharmacist reports of invalid prescriptions. Pharmacists also allegedly dispensed prescriptions with red flags, such as dangerous opioid combinations or excessive dosages. The settlement includes a memorandum of agreement requiring Walmart to establish a hotline for reporting illegal dispensing, monitor pharmacy patterns, and evaluate suspicious prescribers. The case was filed in 2020 and amended in 2022. The government emphasized enforcement of controlled substance laws to prevent opioid abuse.
Source: U.S. Department of Justice (DOJ).
Materials reproduced from https://www.justice.gov/.
No endorsement by the DOJ is implied.
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.